Patrick R. Trucchio
Stock Analyst at HC Wainwright & Co.
(4.05)
# 446
Out of 5,149 analysts
64
Total ratings
56.45%
Success rate
11.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick R. Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DRUG Bright Minds Biosciences | Maintains: Buy | $115 → $145 | $79.81 | +81.68% | 4 | Mar 4, 2026 | |
| VIR Vir Biotechnology | Maintains: Buy | $15 → $20 | $9.48 | +110.97% | 3 | Mar 4, 2026 | |
| PHVS Pharvaris | Reiterates: Buy | $60 | $26.96 | +122.55% | 4 | Mar 3, 2026 | |
| NRXP NRx Pharmaceuticals | Maintains: Buy | $40 → $45 | $1.86 | +2,325.88% | 5 | Mar 3, 2026 | |
| HELP Cybin | Maintains: Buy | $55 → $95 | $8.40 | +1,030.95% | 1 | Mar 2, 2026 | |
| DFTX Definium Therapeutics | Maintains: Buy | $55 → $70 | $18.34 | +281.68% | 1 | Mar 2, 2026 | |
| GHRS GH Research | Maintains: Buy | $35 → $70 | $15.60 | +348.72% | 2 | Mar 2, 2026 | |
| ATAI AtaiBeckley | Maintains: Buy | $15 → $25 | $3.70 | +575.68% | 2 | Mar 2, 2026 | |
| CMPS COMPASS Pathways | Maintains: Buy | $40 → $70 | $7.03 | +895.73% | 1 | Mar 2, 2026 | |
| HRMY Harmony Biosciences Holdings | Reiterates: Buy | $55 | $28.57 | +92.51% | 3 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $510 | $324.17 | +57.33% | 4 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $64.16 | +55.86% | 5 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $9.18 | +662.53% | 6 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.40 | +2,427.17% | 2 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $33.13 | +201.84% | 2 | Feb 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.54 | +1,764.98% | 1 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $29.34 | +70.42% | 2 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.43 | +599.30% | 1 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $1.04 | +866.18% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $25 | $4.15 | +502.41% | 2 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $1.66 | +502.41% | 3 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $50 | $20.90 | +139.23% | 2 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $4.28 | +180.70% | 2 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $27.80 | +187.77% | 2 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $5.53 | +1,256.24% | 1 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $7.01 | +613.26% | 2 | Sep 12, 2025 |
Bright Minds Biosciences
Mar 4, 2026
Maintains: Buy
Price Target: $115 → $145
Current: $79.81
Upside: +81.68%
Vir Biotechnology
Mar 4, 2026
Maintains: Buy
Price Target: $15 → $20
Current: $9.48
Upside: +110.97%
Pharvaris
Mar 3, 2026
Reiterates: Buy
Price Target: $60
Current: $26.96
Upside: +122.55%
NRx Pharmaceuticals
Mar 3, 2026
Maintains: Buy
Price Target: $40 → $45
Current: $1.86
Upside: +2,325.88%
Cybin
Mar 2, 2026
Maintains: Buy
Price Target: $55 → $95
Current: $8.40
Upside: +1,030.95%
Definium Therapeutics
Mar 2, 2026
Maintains: Buy
Price Target: $55 → $70
Current: $18.34
Upside: +281.68%
GH Research
Mar 2, 2026
Maintains: Buy
Price Target: $35 → $70
Current: $15.60
Upside: +348.72%
AtaiBeckley
Mar 2, 2026
Maintains: Buy
Price Target: $15 → $25
Current: $3.70
Upside: +575.68%
COMPASS Pathways
Mar 2, 2026
Maintains: Buy
Price Target: $40 → $70
Current: $7.03
Upside: +895.73%
Harmony Biosciences Holdings
Feb 25, 2026
Reiterates: Buy
Price Target: $55
Current: $28.57
Upside: +92.51%
Feb 18, 2026
Reiterates: Buy
Price Target: $510
Current: $324.17
Upside: +57.33%
Feb 10, 2026
Reiterates: Buy
Price Target: $100
Current: $64.16
Upside: +55.86%
Feb 10, 2026
Reiterates: Buy
Price Target: $70
Current: $9.18
Upside: +662.53%
Feb 10, 2026
Reiterates: Buy
Price Target: $10
Current: $0.40
Upside: +2,427.17%
Feb 4, 2026
Reiterates: Buy
Price Target: $100
Current: $33.13
Upside: +201.84%
Jan 22, 2026
Reiterates: Buy
Price Target: $10
Current: $0.54
Upside: +1,764.98%
Dec 22, 2025
Reiterates: Buy
Price Target: $50
Current: $29.34
Upside: +70.42%
Dec 8, 2025
Initiates: Buy
Price Target: $10
Current: $1.43
Upside: +599.30%
Nov 17, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $1.04
Upside: +866.18%
Nov 12, 2025
Maintains: Buy
Price Target: $30 → $25
Current: $4.15
Upside: +502.41%
Nov 3, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $1.66
Upside: +502.41%
Oct 24, 2025
Maintains: Buy
Price Target: $10 → $50
Current: $20.90
Upside: +139.23%
Oct 20, 2025
Reiterates: Buy
Price Target: $12
Current: $4.28
Upside: +180.70%
Oct 10, 2025
Reiterates: Buy
Price Target: $80
Current: $27.80
Upside: +187.77%
Sep 16, 2025
Reiterates: Buy
Price Target: $75
Current: $5.53
Upside: +1,256.24%
Sep 12, 2025
Reiterates: Buy
Price Target: $50
Current: $7.01
Upside: +613.26%